Related Experiment Video
Updated: Mar 18, 2026
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs
Aurora Crespo-Jara1, Ramón González Manzano, Maribel Lopera Sierra
1From the *Plataforma de Oncología Hospital Quirón Torrevieja, Cátedra Oncología Multidisciplinar Universidad Católica San Antonio de Murcia, Murcia, Spain; and †Advanced Accelerator Applications, New York, NY.
Abstract:
We present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera (Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including all the available active drugs in soft tissue sarcomas. The high expression of somatostatin receptors was shown by microarrays and Octreoscan. The overall duration of response exceeded 1 year.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021